A

AccurKardia pricing

No price, unit or structure is published. What is published is regulatory: two FDA 510(k) clearances for the AccurECG Analysis System, K223013 in June 2023 and K252361 for version 2.0 in December 2025, the second covering single lead ambulatory ECG for up to ten days in adults.

Pricing terms

How AccurKardia pricing works

Pricing model
Not published. Sold to cardiac monitoring companies, device manufacturers, hospitals and independent diagnostic testing facilities; unit of charge unstated
Implementation
Not published. The platform is described as device agnostic with flexible customer integrations.

The buyers are different businesses: a monitoring company reselling interpretation, a device maker embedding it and a hospital consuming it directly. The company announced multi year agreements with Specialized Medical and Wellysis in 2026 without terms, and describes version 2.0 as built to process high volume ECG streams at lower cost, which suggests volume matters to price without stating how.

Compared on price

AccurKardia pricing against its alternatives

Published prices for AccurKardia and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All AccurKardia alternatives →

  • A
    AccurKardia
    No published price
  • H
    HeartSciences
    No published price
  • E
    Eko Health
    $119.99 per clinician per year (Eko+); SENSORA by quote
  • C
    Ceribell
    No published price
  • I
    iRhythm Technologies
    No price published; reimbursed diagnostic service billed under procedure codes
  • O
    Octagos Health
    No prices published; four packages (Pro, Premium, Flex, Custom) billed per billable monthly transmission, as a fixed monthly fee, or on a custom plan; integration at no cost
  • A
    Anumana
    No published price
  • V
    Vivalink
    No published price
  • N
    Nanowear
    No published price
Questions

AccurKardia pricing, answered

How much does AccurKardia cost?

AccurKardia does not publish a price. What is published is regulatory: two FDA 510(k) clearances for the AccurECG Analysis System, K223013 in June 2023 and K252361 for version 2.0 in December 2025, the second covering single lead ambulatory ECG for up to ten days in adults.

Does AccurKardia charge an implementation fee?

Not published. The platform is described as device agnostic with flexible customer integrations.